Novartis wins unanimous support from FDA panel on groundbreaking CAR-T med
admin 12th July 2017 Uncategorised 0All eyes in the drug industry turned to the FDA’s Oncologic Drugs Advisory Committee meeting Wednesday, where Novartis won crucial backing for its potentially groundbreaking lead CAR-T drug.
More: Novartis wins unanimous support from FDA panel on groundbreaking CAR-T med
Source: fierce